These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
712 related items for PubMed ID: 17717454
1. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW. Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454 [Abstract] [Full Text] [Related]
4. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK. Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152 [Abstract] [Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver Transpl; 2002 Sep; 8(9):765-74. PubMed ID: 12200775 [Abstract] [Full Text] [Related]
6. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT. Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158 [Abstract] [Full Text] [Related]
8. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria. Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN. Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852 [Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria. Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH. Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620 [Abstract] [Full Text] [Related]
10. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma. Piardi T, Gheza F, Ellero B, Woehl-Jaegle ML, Ntourakis D, Cantu M, Marzano E, Audet M, Wolf P, Pessaux P. Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632 [Abstract] [Full Text] [Related]
11. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Nemes B, Gelley F, Piros L, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A. Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108 [Abstract] [Full Text] [Related]
12. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Wai CT, Woon WA, Tan YM, Lee KH, Tan KC. Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059 [Abstract] [Full Text] [Related]
13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW. J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672 [Abstract] [Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM. Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377 [Abstract] [Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M. Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [Abstract] [Full Text] [Related]
16. Milan criteria versus San Francisco criteria in hepatocellular carcinoma: our center's experience. Sánchez Antolín G, García Pajares F, Pérez E, Villacastín E, Ruiz Rebollo L, Sánchez DP, Cítores MA, Velicia Llames R. Transplant Proc; 2009 Apr; 41(3):1012-3. PubMed ID: 19376413 [Abstract] [Full Text] [Related]
17. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW. Clin Transplant; 2007 Apr; 21(6):696-701. PubMed ID: 17988261 [Abstract] [Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria. Sotiropoulos GC, Molmenti EP, Omar OS, Bockhorn M, Brokalaki EI, Lang H, Frilling A, Broelsch CE, Malagó M. Eur J Med Res; 2006 Nov 30; 11(11):467-70. PubMed ID: 17182358 [Abstract] [Full Text] [Related]
19. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG. Arch Surg; 2001 Jan 30; 136(1):25-30; discussion 31. PubMed ID: 11146770 [Abstract] [Full Text] [Related]
20. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J. Liver Transpl; 2001 Oct 30; 7(10):877-83. PubMed ID: 11679986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]